PL2646462T3 - Sposoby i kompozycje do monitorowania aktywności fagocytarnej - Google Patents
Sposoby i kompozycje do monitorowania aktywności fagocytarnejInfo
- Publication number
- PL2646462T3 PL2646462T3 PL11805939T PL11805939T PL2646462T3 PL 2646462 T3 PL2646462 T3 PL 2646462T3 PL 11805939 T PL11805939 T PL 11805939T PL 11805939 T PL11805939 T PL 11805939T PL 2646462 T3 PL2646462 T3 PL 2646462T3
- Authority
- PL
- Poland
- Prior art keywords
- compositions
- methods
- phagocytic activity
- monitoring
- monitoring phagocytic
- Prior art date
Links
- 238000000034 method Methods 0.000 title 1
- 239000000203 mixture Substances 0.000 title 1
- 238000012544 monitoring process Methods 0.000 title 1
- 230000000242 pagocytic effect Effects 0.000 title 1
Classifications
-
- G—PHYSICS
- G01—MEASURING; TESTING
- G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
- G01N33/00—Investigating or analysing materials by specific methods not covered by groups G01N1/00 - G01N31/00
- G01N33/48—Biological material, e.g. blood, urine; Haemocytometers
- G01N33/50—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing
- G01N33/68—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing involving proteins, peptides or amino acids
- G01N33/6893—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing involving proteins, peptides or amino acids related to diseases not provided for elsewhere
- G01N33/6896—Neurological disorders, e.g. Alzheimer's disease
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07K—PEPTIDES
- C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
- C07K14/435—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
- C07K14/46—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans from vertebrates
- C07K14/47—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans from vertebrates from mammals
- C07K14/4701—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans from vertebrates from mammals not used
- C07K14/4711—Alzheimer's disease; Amyloid plaque core protein
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07K—PEPTIDES
- C07K16/00—Immunoglobulins [IGs], e.g. monoclonal or polyclonal antibodies
- C07K16/18—Immunoglobulins [IGs], e.g. monoclonal or polyclonal antibodies against material from animals or humans
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07K—PEPTIDES
- C07K2317/00—Immunoglobulins specific features
- C07K2317/30—Immunoglobulins specific features characterized by aspects of specificity or valency
- C07K2317/34—Identification of a linear epitope shorter than 20 amino acid residues or of a conformational epitope defined by amino acid residues
-
- G—PHYSICS
- G01—MEASURING; TESTING
- G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
- G01N2800/00—Detection or diagnosis of diseases
- G01N2800/28—Neurological disorders
- G01N2800/2814—Dementia; Cognitive disorders
-
- G—PHYSICS
- G01—MEASURING; TESTING
- G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
- G01N2800/00—Detection or diagnosis of diseases
- G01N2800/28—Neurological disorders
- G01N2800/2814—Dementia; Cognitive disorders
- G01N2800/2821—Alzheimer
Landscapes
- Health & Medical Sciences (AREA)
- Chemical & Material Sciences (AREA)
- Life Sciences & Earth Sciences (AREA)
- Organic Chemistry (AREA)
- Engineering & Computer Science (AREA)
- Molecular Biology (AREA)
- Biomedical Technology (AREA)
- Proteomics, Peptides & Aminoacids (AREA)
- Biochemistry (AREA)
- General Health & Medical Sciences (AREA)
- Medicinal Chemistry (AREA)
- Immunology (AREA)
- Genetics & Genomics (AREA)
- Biophysics (AREA)
- Neurology (AREA)
- Hematology (AREA)
- Urology & Nephrology (AREA)
- Zoology (AREA)
- Toxicology (AREA)
- Gastroenterology & Hepatology (AREA)
- Microbiology (AREA)
- General Physics & Mathematics (AREA)
- Pathology (AREA)
- Food Science & Technology (AREA)
- Analytical Chemistry (AREA)
- Physics & Mathematics (AREA)
- Cell Biology (AREA)
- Biotechnology (AREA)
- Neurosurgery (AREA)
- Peptides Or Proteins (AREA)
- Investigating Or Analysing Biological Materials (AREA)
- Measuring Or Testing Involving Enzymes Or Micro-Organisms (AREA)
Applications Claiming Priority (3)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| US41755910P | 2010-11-29 | 2010-11-29 | |
| EP11805939.3A EP2646462B1 (en) | 2010-11-29 | 2011-11-28 | Methods and compositions for monitoring phagocytic activity |
| PCT/IB2011/002999 WO2012073111A2 (en) | 2010-11-29 | 2011-11-28 | Methods and compositions for monitoring phagocytic activity |
Publications (1)
| Publication Number | Publication Date |
|---|---|
| PL2646462T3 true PL2646462T3 (pl) | 2017-10-31 |
Family
ID=45464639
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| PL11805939T PL2646462T3 (pl) | 2010-11-29 | 2011-11-28 | Sposoby i kompozycje do monitorowania aktywności fagocytarnej |
Country Status (6)
| Country | Link |
|---|---|
| US (3) | US11231426B2 (pl) |
| EP (1) | EP2646462B1 (pl) |
| DK (1) | DK2646462T3 (pl) |
| ES (1) | ES2628596T3 (pl) |
| PL (1) | PL2646462T3 (pl) |
| WO (1) | WO2012073111A2 (pl) |
Families Citing this family (3)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| PL2646462T3 (pl) * | 2010-11-29 | 2017-10-31 | Akershus Univ | Sposoby i kompozycje do monitorowania aktywności fagocytarnej |
| WO2020163794A1 (en) * | 2019-02-08 | 2020-08-13 | Msdx, Inc. | Detection of brain-derived debris in recirculating phagocytes |
| CN117098993A (zh) * | 2021-03-08 | 2023-11-21 | 阿克斯胡斯大学医院Hf | 清除测定 |
Family Cites Families (8)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| WO1997037228A1 (en) * | 1996-03-29 | 1997-10-09 | The Trustees Of Boston University | Methods for diagnosing and treating alzheimer's disease |
| US6022859A (en) * | 1996-11-15 | 2000-02-08 | Wisconsin Alumni Research Foundation | Inhibitors of β-amyloid toxicity |
| US6750324B1 (en) * | 1997-12-02 | 2004-06-15 | Neuralab Limited | Humanized and chimeric N-terminal amyloid beta-antibodies |
| US7964192B1 (en) | 1997-12-02 | 2011-06-21 | Janssen Alzheimer Immunotherapy | Prevention and treatment of amyloidgenic disease |
| AR038568A1 (es) | 2002-02-20 | 2005-01-19 | Hoffmann La Roche | Anticuerpos anti-a beta y su uso |
| DK1701968T3 (da) | 2003-12-17 | 2015-06-22 | Wyeth Llc | Immunogene peptid-bærer-konjugater og fremgangsmåder til deres fremstilling |
| US20110092445A1 (en) * | 2008-07-25 | 2011-04-21 | Abbott Laboratories | Amyloid ß peptide analogues, oligomers thereof, processes for preparing and composi-tions comprising said analogues or oligomers, and their uses |
| PL2646462T3 (pl) * | 2010-11-29 | 2017-10-31 | Akershus Univ | Sposoby i kompozycje do monitorowania aktywności fagocytarnej |
-
2011
- 2011-11-28 PL PL11805939T patent/PL2646462T3/pl unknown
- 2011-11-28 EP EP11805939.3A patent/EP2646462B1/en active Active
- 2011-11-28 ES ES11805939.3T patent/ES2628596T3/es active Active
- 2011-11-28 WO PCT/IB2011/002999 patent/WO2012073111A2/en not_active Ceased
- 2011-11-28 US US13/989,950 patent/US11231426B2/en active Active
- 2011-11-28 DK DK11805939.3T patent/DK2646462T3/en active
-
2022
- 2022-01-24 US US17/582,355 patent/US11988677B2/en active Active
-
2024
- 2024-05-17 US US18/667,681 patent/US20240369577A1/en active Pending
Also Published As
| Publication number | Publication date |
|---|---|
| US20240369577A1 (en) | 2024-11-07 |
| WO2012073111A3 (en) | 2012-11-15 |
| US20220341948A1 (en) | 2022-10-27 |
| EP2646462B1 (en) | 2017-04-05 |
| ES2628596T3 (es) | 2017-08-03 |
| US20140051084A1 (en) | 2014-02-20 |
| DK2646462T3 (en) | 2017-07-03 |
| US11231426B2 (en) | 2022-01-25 |
| WO2012073111A2 (en) | 2012-06-07 |
| US11988677B2 (en) | 2024-05-21 |
| EP2646462A2 (en) | 2013-10-09 |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| IL220939A0 (en) | Compounds and methods | |
| EP2523664A4 (en) | COMPOUNDS AND METHODS | |
| EP2739974A4 (en) | METHOD AND COMPOSITIONS FOR HEART ERROR MONITORING | |
| IL224390B (en) | Compositions and methods for targeted thermal modulation | |
| ZA201303436B (en) | Oral engagement assemblies | |
| PT3636274T (pt) | Composições para modular a atividade das citocinas gama-c | |
| PH12013500698A1 (en) | Hair-mending compositions and associated methods | |
| IL220812A0 (en) | Compounds and methods | |
| EP2523560A4 (en) | CONNECTIONS AND METHODS | |
| ZA201303949B (en) | Compounds and methods for skin repair | |
| GB201018650D0 (en) | Methods and compositions | |
| IL220850A0 (en) | Pigmentation-preventing or-ameliorating agent | |
| PL2654402T3 (pl) | Zraszacz | |
| PL2618939T3 (pl) | Zraszacz | |
| PL2646462T3 (pl) | Sposoby i kompozycje do monitorowania aktywności fagocytarnej | |
| GB201021179D0 (en) | Monitoring of clearance | |
| GB201004450D0 (en) | Compounds and methods relating thereto | |
| PL2371665T3 (pl) | Monitorowanie stanu | |
| TWM386745U (en) | Monitor structure | |
| IL223436A (en) | Methods for preparing tetranor - pgdm and tetranor - pgjm | |
| PL2654403T3 (pl) | Zraszacz | |
| TWM391234U (en) | Monitor | |
| TWM390509U (en) | Monitor | |
| GB201002019D0 (en) | Powershot | |
| TWM386756U (en) | Sun-shading structure for fruits |